Manipal Health Enterprises Limited (BOM:544847)

Market Cap	923.00B
Revenue (ttm)	111.89B +131.2%
Net Income	8.74B +106.9%
EPS	7.46 +98.5%
Shares Out	n/a
PE Ratio	105.65
Forward PE	66.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,205
Open	727.20
Previous Close	716.15
Day's Range	698.20 - 727.20
52-Week Range	626.00 - 813.70
Beta	n/a
Analysts	Buy
Price Target	842.14 (+19.96%)
Earnings Date	Aug 20, 2026

About BOM:544847

Manipal Health Enterprises Limited operates hospitals in India. The company offers services, such as multi-specialty tertiary and quaternary care through its network of hospitals. Its services include accident and emergency care, cancer care, cardiology, organ transplants, obstetrics and gynaecology, neurology, nephrology, orthopaedics, proctology, rheumatology, and urology. The company also offers medical services, including robotic spine surgery, bariatric surgery, head and neck surgery, liver transplantation, dialysis, laparoscopic surgery, ...

• Industry: General Medical and Surgical Hospitals
• Founded: 1991
• Employees: 24,240
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544847

Financial Performance

In fiscal year 2026, BOM:544847's revenue was 103.36 billion, an increase of 25.40% compared to the previous year's 82.42 billion. Earnings were 8.92 billion, a decrease of -16.24%.

Analyst Summary

According to 7 analysts, the average rating for 544847 stock is "Buy." The 12-month stock price target is ₹842.14, which is an increase of 19.96% from the latest price.

Price Target

₹842.14

(19.96% upside)

Analyst Consensus: Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 16, 2026

Data Sources Report a data error